Bohai Pharmaceuticals Group, Inc.

company.status.inactive

CIK 1443242fmd_02YWXJV6CEZZW1B3MZDWQJ41B1Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jul 01, 2009 to Sep 30, 2014, 18 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014
Total revenues	–	–	–	152	175
Cost of revenue	–	17	34	37	42
Gross profit	–	64	104	115	133
Research and development	–	0	0	0	0
Selling, general and administrative	–	46	73	83	98
Total operating expenses	–	46	75	88	100
Operating income	–	18	28	27	32
Interest expense	–	4	11	(2)	(2)
Interest and investment income	–	0	0	0	0
Other non-operating income (expense)	–	1	(11)	(1)	1
Income before taxes	–	19	17	26	32
Income tax expense	–	5	7	(7)	(10)
Net income from continuing operations	–	14	10	33	41
Net income	9	14	10	19	22
Net income to common shareholders	–	14	10	19	22